(Q72909489)
Statements
A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group (English)
S A Montgomery
A McIntyre
M Osterheider
P Sarteschi
W Zitterl
J Zohar
M Birkett